Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults.
about
Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap n collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2)Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase(1.)Interaction of the molecular chaperone Hsp70 with human NAD(P)H:quinone oxidoreductase 1Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studiesSecondary acute myeloid leukaemia with monosomy 7 in identical adult twins.Exploring the Potential of Venom from Nasonia vitripennis as Therapeutic Agent with High-Throughput Screening ToolsNAD(P)H: quinone oxidoreductase 1 deficiency conjoint with marginal vitamin C deficiency causes cigarette smoke induced myelodysplastic syndromes.Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia.Quinone-induced enhancement of DNA cleavage by human topoisomerase IIalpha: adduction of cysteine residues 392 and 405.Targeting of T/Tn antigens with a plant lectin to kill human leukemia cells by photochemotherapy.NQO1 stabilizes p53 through a distinct pathway.Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review.Genetic susceptibility to benzene toxicity in humans.Quinone reductases multitasking in the metabolic world.NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North ChinaOver-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11.NQO1, MPO, and the risk of lung cancer: a HuGE review.NAD(P)H:quinone oxidoreductase 1 (NQO1) competes with 20S proteasome for binding with C/EBPα leading to its stabilization and protection against radiation-induced myeloproliferative disease.A Case-Control Study of Involvement of Oxidative DNA Damage and Alteration of Antioxidant Defense System in Patients with Basal Cell Carcinoma: Modulation by Tumor RemovalDisruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to radiation-induced myeloproliferative disease.NQO1 inhibits proteasome-mediated degradation of HIF-1α.Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.Secondary Adult Acute Myeloid Leukemia: a Review of Our Evolving Understanding of a Complex Disease Process.Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population.Detection of quinone oxidoreductase 1 (NQO1) single-nucleotide polymorphisms (SNP) related to benzene metabolism in immortalized B lymphocytes from a Chinese Han population.The relationship between NQO1 C609T and CAT C-262Tgenetic polymorphisms and the risk of age-related cataracts.E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients.Competitive amplification and unspecific amplification in polymerase chain reaction with confronting two-pair primers.Benzene toxicity: The role of the susceptibility factor NQO1 in bone marrow endothelial cell signaling and function.Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalities.Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems.Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t-AML/MDS.Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients.
P2860
Q23919661-56788060-BE55-4109-BDB5-4A27B1EC0792Q24302315-13C079CD-21BE-4576-A0CA-E5C7351385ACQ28217043-E9F6CA7D-735E-4DD0-A0DB-249E4BC9351EQ28307135-254129F2-9F29-4567-BF7A-0A92120DBC66Q33341029-F7BF544A-DE05-4884-A06D-2AD8475ABAC1Q33360864-055EBC28-2522-446B-8C23-B3B04AEB8332Q33395692-EA0AD932-C001-458C-858E-14F180A3B372Q33944747-DD33DD58-BE7D-4F58-8B56-FAE4919FCAD7Q33957966-B6FDD7A0-36AE-493D-AD11-319E8DCE3AFEQ33999425-71B5B710-2D2D-458A-B350-43F82EA1F651Q34016489-17543612-8B49-468B-9427-E697F5124164Q34191852-6CA24F4D-F7AC-43C7-B157-92906B6D756DQ34554415-52520AC7-88C5-4796-958B-11F4D951F849Q34846124-4E4713C2-90D5-4D08-9FCC-0B18F44D6116Q35956182-0FD71ABF-48DF-47F3-8012-89E497712B04Q36190589-748253F3-8541-4F7A-8A6A-CF8346A8E643Q36248886-48306663-3FAB-4BA1-9066-6A3381F4850DQ36260511-04F9242E-D4CF-4C3D-88B6-F332ACDB11F9Q36451851-800D17E4-0DEE-4C71-8FDF-AB62E48D659DQ36537212-DC9B047B-AD9C-47FB-BCFC-1CD83AC70C10Q37002112-4FCF147C-1668-4D2B-A73D-82CBCDCDDFDDQ37519069-8478A9D6-01C1-44D8-9C12-745F17870D26Q37775981-008DD6F5-09C1-4F6E-A1FD-0A15EF9547A8Q37810123-929D72E5-F050-49B5-8B41-0E1A60792F80Q38542828-2294CE8D-E7FD-43AE-A4A5-B798976BA724Q39330661-EF274152-563B-4A82-AFA9-2C85A600D286Q39714999-E0E6CA56-288A-450B-A92A-F5D3EEFA1EC1Q41066019-E956AE0B-889F-496A-86DB-F7EFF8F9EAAFQ41817177-5CC30ACA-9241-4260-92FA-6C31FD576446Q42016531-E8919DA5-130E-4E32-97C5-CF05986D9B97Q42048712-F0D0A28D-C6EA-4C7F-B3CC-ED5ADD86C04AQ43889352-C715CD30-9DBF-4642-BA06-CD8B0810FACBQ44279157-F7710EA7-FCAF-4E61-B76F-3D73037BF6FBQ44937875-53A0E026-7DB9-4463-A646-6F2DCC4A458DQ54642861-0D6F5136-AB8C-45C5-AE9B-A61039EB1139
P2860
Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Low NAD(P)H:quinone oxidoreduc ...... k of acute leukemia in adults.
@ast
Low NAD(P)H:quinone oxidoreduc ...... k of acute leukemia in adults.
@en
type
label
Low NAD(P)H:quinone oxidoreduc ...... k of acute leukemia in adults.
@ast
Low NAD(P)H:quinone oxidoreduc ...... k of acute leukemia in adults.
@en
prefLabel
Low NAD(P)H:quinone oxidoreduc ...... k of acute leukemia in adults.
@ast
Low NAD(P)H:quinone oxidoreduc ...... k of acute leukemia in adults.
@en
P2093
P356
P1433
P1476
Low NAD(P)H:quinone oxidoreduc ...... k of acute leukemia in adults.
@en
P2093
Cartwright R
Rollinson S
Wiemels JL
P304
P356
10.1182/BLOOD.V97.5.1422
P407
P577
2001-03-01T00:00:00Z